|
GS135315: alcohol preference 3 QTL (Ap3q, Published QTL Chr 4)
|
|
GS135831: fluctuating asymmetry QTL 1 (Faq1, Published QTL Chr 4)
|
|
GS196252: GO:0052646 alditol phosphate metabolic process
|
|
GS123554: vinclozolin interacting genes (MeSH:C025643) in CTD
|
|
GS135544: corpus callosum hemisphere surface size 2 (Ccrs2, Published QTL Chr 4)
|
|
GS204629: GO:1901564 organonitrogen compound metabolic process
|
|
GS136518: phospholipid transfer protein inducibility QTL 1 (Pltiq1, Published QTL Chr 4)
|
|
GS123718: Ethinyl Estradiol interacting genes (MeSH:D004997) in CTD
|
|
GS135221: aromatase activity QTL 2 (Aaiq2, Published QTL Chr 4)
|
|
GS136955: weight 3 (Wght3, Published QTL Chr 4)
|
|
GS201235: GO:0046488 phosphatidylinositol metabolic process
|
|
GS135220: aromatase activity QTL 1 (Aaiq1, Published QTL Chr 4)
|
|
GS199036: GO:0016298 lipase activity
|
|
GS84321: pentobarbital withdrawal Chr4 (Published QTL)
|
|
GS178461: GO:0009987 cellular process
|
|
GS182834: GO:0005623 cell
|
|
GS192041: GO:0043169 cation binding
|
|
GS210507: GO:0006950 response to stress
|
|
GS84165: ethanol conditioned taste aversion (Published QTL, Chr 4)
|
|
GS129116: cytokine induced activation 3 (Cinda3 Published QTL Chr 4)
|
|
GS136060: immunoregulatory 2 (Im2, Published QTL Chr 4)
|
|
GS83998: cocaine and amphetamine-regulated transcript QTL 2 (Crq2, Published QTL, Chr 4)
|
|
GS193268: GO:0005575 cellular_component
|
|
GS196943: GO:0008152 metabolic process
|
|
GS136150: "lupus in MRL and B6 F2 cross, QTL 1" (Lmb1, Published QTL Chr 4)
|
|
GS202625: GO:0045017 glycerolipid biosynthetic process
|
|
GS196941: GO:0008150 biological_process
|
|
GS126040: Tetracycline interacting genes (MeSH:D013752) in CTD
|
|
GS208043: GO:0016788 hydrolase activity, acting on ester bonds
|
|
GS136705: systemic lupus erythmatosus suppressor 2 (Sles2, Published QTL Chr 4)
|
|
GS135567: cytokine deficiency colitis susceptibility 9 (Cdcs9, Published QTL Chr 4)
|
|
GS206874: GO:0006650 glycerophospholipid metabolic process
|
|
GS136621: sucrose consumption 2 (Scon2, Published QTL Chr 4)
|
|
GS180296: GO:0005509 calcium ion binding
|
|
GS207857: GO:0009058 biosynthetic process
|
|
GS136608: colon tumor susceptibility 11 (Scc11, Published QTL Chr 4)
|
|
GS136443: peak bone mineral density 3 (Pbmd3, Published QTL Chr 4)
|
|
GS201023: GO:0071704 organic substance metabolic process
|
|
GS84164: cocaine related behavior (Published QTL, Chr 4)
|
|
GS135893: gastritis type A susceptibility locus 1 (Gasa1, Published QTL Chr 4)
|
|
GS128576: Ethanol induced LORR Chr# 4
|
|
GS84163: alcohol preference 3 QTL (Ap3q, Published QTL, Chr 4)
|
|
GS136719: susceptibility to lung cancer 21 (Sluc21, Published QTL Chr 4)
|
|
GS193286: GO:0004620 phospholipase activity
|
|
GS191106: GO:0044464 cell part
|
|
GS135899: granulosa cell tumorigenesis 1 (Gct1, Published QTL Chr 4)
|
|
GS177404: GO:0005737 cytoplasm
|
|
GS177094: GO:0006629 lipid metabolic process
|
|
GS197244: GO:0044237 cellular metabolic process
|
|
GS127205: Tamoxifen interacting genes (MeSH:D013629) in CTD
|
|
GS196055: GO:0008654 phospholipid biosynthetic process
|
|
GS179132: GO:0044255 cellular lipid metabolic process
|
|
GS136559: QTL for body weight independent of sex 1 (Qbis1, Published QTL Chr 4)
|
|
GS206546: GO:0036148 phosphatidylglycerol acyl-chain remodeling
|
|
GS136575: recognized antigen from MCA-induced tumor 1 (Ramt1, Published QTL Chr 4)
|
|
GS136689: skull morphology 6 (Skull6, Published QTL Chr 4)
|
|
GS207923: GO:0034641 cellular nitrogen compound metabolic process
|
|
GS135775: epistatic circling B C57L/J (Eclb, Published QTL Chr 4)
|
|
GS181533: GO:0046872 metal ion binding
|
|
GS191135: GO:0016788 hydrolase activity, acting on ester bonds
|
|
GS135803: elevated serum gp70 1 (Elsgp1, Published QTL Chr 4)
|
|
GS192296: GO:0006796 phosphate-containing compound metabolic process
|
|
GS198263: GO:0005488 binding
|
|
GS84166: METH responses for climbing (Published QTL, Chr 4)
|
|
GS135839: femoral bone trait QTL 2 (Fbtq2, Published QTL Chr 4)
|
|
GS182238: GO:0016298 lipase activity
|
|
GS136823: triglyceride QTL 3 (Tgq3, Published QTL Chr 4)
|
|
GS193270: GO:0005576 extracellular region
|
|
GS195151: GO:0019637 organophosphate metabolic process
|
|
GS198639: GO:0046471 phosphatidylglycerol metabolic process
|
|
GS210666: GO:0044106 cellular amine metabolic process
|
|
GS136046: insulin dependent diabetes susceptibility 25 (Idd25, Published QTL Chr 4)
|
|
GS208037: GO:0016787 hydrolase activity
|
|
GS198323: GO:0046872 metal ion binding
|
|
GS135460: bone mineral density 6 (Bomd6, Published QTL Chr 4)
|
|
GS185770: GO:0006644 phospholipid metabolic process
|
|
GS36544: Striatum Gene expression correlates of Dowel Test - Time B Sec in Females BXD
|
|
GS135509: body weight at 8 weeks QTL 2 (Bw8q2, Published QTL Chr 4)
|
|
GS209235: GO:0006793 phosphorus metabolic process
|
|
GS201237: GO:0046486 glycerolipid metabolic process
|
|
GS204326: GO:0019752 carboxylic acid metabolic process
|
|
GS26279: Striatum Gene expression correlates of Mechanical Sensitivity-Von Frey Threshold in Females & Males BXD
|
|
GS135852: fecundity QTL 2 (Fecq2, Published QTL Chr 4)
|
|
GS184447: GO:0044424 intracellular part
|
|
GS197076: GO:0005509 calcium ion binding
|
|
GS207862: GO:0009056 catabolic process
|
|
GS205047: GO:0006807 nitrogen compound metabolic process
|
|
GS210357: GO:0044249 cellular biosynthetic process
|
|
GS180452: GO:0044237 cellular metabolic process
|
|
GS202555: GO:0043436 oxoacid metabolic process
|
|
GS209863: GO:0050896 response to stimulus
|
|
GS200827: GO:0006066 alcohol metabolic process
|
|
GS192074: GO:1901575 organic substance catabolic process
|
|
GS198072: GO:0042439 ethanolamine-containing compound metabolic process
|
|
GS136860: thermal pain response 1 (Tpnr1, Published QTL Chr 4)
|
|
GS180164: GO:0008150 biological_process
|
|
GS135416: beta-carboline-induced seizures 1 (Bis1, Published QTL Chr 4)
|
|
GS206877: GO:0006658 phosphatidylserine metabolic process
|
|
GS136050: insulin dependent diabetes susceptibility 9 (Idd9, Published QTL Chr 4)
|
|
GS194460: GO:0090407 organophosphate biosynthetic process
|
|
GS26214: Cerebellum Gene expression correlates of Thermal Nociception Hargreaves' Test in Females BXD
|
|
GS136730: susceptibility to lung cancer 6 (Sluc6, Published QTL Chr 4)
|
|
GS185585: GO:0044710 single-organism metabolic process
|
|
GS205255: GO:0044238 primary metabolic process
|
|
GS136820: triglyceride level suppressor 1 (Tgls1, Published QTL Chr 4)
|
|
GS129075: alloantigen response 2 (Alan2 Published QTL Chr 4)
|
|
GS135245: adiposity 12 (Adip12, Published QTL Chr 4)
|
|
GS194017: GO:0036151 phosphatidylcholine acyl-chain remodeling
|
|
GS135480: bone response to mechanical loading 13 (Brml13, Published QTL Chr 4)
|
|
GS135770: ear healing QTL 2 (Earheal2, Published QTL Chr 4)
|
|
GS177572: GO:0016042 lipid catabolic process
|
|
GS194018: GO:0036150 phosphatidylserine acyl-chain remodeling
|
|
GS136788: TallyHo associated mesenteric fat pad weight (Tafat, Published QTL Chr 4)
|
|
GS209232: GO:0006796 phosphate-containing compound metabolic process
|
|
GS210212: GO:0005575 cellular_component
|
|
GS208978: GO:0043169 cation binding
|
|
GS135917: graft-versus-host disease 2 (Gvhd2, Published QTL Chr 4)
|
|
GS136148: lithogenic gene 8 (Lith8, Published QTL Chr 4)
|
|
GS196667: GO:0008610 lipid biosynthetic process
|
|
GS210163: GO:0006082 organic acid metabolic process
|
|
GS135477: bone response to mechanical loading 10 (Brml10, Published QTL Chr 4)
|
|
GS188399: GO:0044238 primary metabolic process
|
|
GS194019: GO:0036152 phosphatidylethanolamine acyl-chain remodeling
|
|
GS190954: GO:0009056 catabolic process
|
|
GS136056: IgA nephropathy QTL 2 (Ignpq2, Published QTL Chr 4)
|
|
GS209455: GO:0003824 catalytic activity
|
|
GS184218: GO:0071704 organic substance metabolic process
|
|
GS202602: GO:0006644 phospholipid metabolic process
|
|
GS136571: radiation induced acute myeloid leukemia 3 (Raml3, Published QTL Chr 4)
|
|
GS136567: retinoic acid induced forelimb autopod reduction 2 (Rafar2, Published QTL Chr 4)
|
|
GS135920: graft-versus host disease 5 (Gvhd5, Published QTL Chr 4)
|
|
GS135330: autoimmune renal vasculitis 2 (Arvm2, Published QTL Chr 4)
|
|
GS210214: GO:0005576 extracellular region
|
|
GS197967: GO:0052689 carboxylic ester hydrolase activity
|
|
GS203381: GO:0009308 amine metabolic process
|
|
GS135741: dystrophic cardiac calcinosis 2 (Dyscalc2, Published QTL Chr 4)
|
|
GS209009: GO:1901576 organic substance biosynthetic process
|
|
GS192299: GO:0006793 phosphorus metabolic process
|
|
GS197644: GO:0006954 inflammatory response
|
|
GS178401: GO:0019637 organophosphate metabolic process
|
|
GS194309: GO:0016042 lipid catabolic process
|
|
GS182835: GO:0005622 intracellular
|
|
GS136202: lung tumor shape-determining 4 (Ltsd4, Published QTL Chr 4)
|
|
GS202415: GO:0044710 single-organism metabolic process
|
|
GS213074: Genes with suggestive difference in (B6PF1) vs (PB6F1 + B6 + PWD) comparison
|
|
GS129084: atherosclerosis susceptibility QTL 1 (Athsq1 Published QTL Chr 4)
|
|
GS194505: GO:1901135 carbohydrate derivative metabolic process
|
|
GS181177: GO:0052689 carboxylic ester hydrolase activity
|
|
GS207903: GO:0044281 small molecule metabolic process
|
|
GS136667: skin tumor susceptibility 7 (Skts7, Published QTL Chr 4)
|
|
GS194087: GO:0003674 molecular_function
|
|
GS177356: GO:0003674 molecular_function
|
|
GS210231: GO:0004620 phospholipase activity
|
|
GS204383: GO:0006575 cellular modified amino acid metabolic process
|
|
GS189860: GO:0043167 ion binding
|
|
GS136880: tooth shape 6 (Tshp6, Published QTL Chr 4)
|
|
GS136757: startle response 2 (Start2, Published QTL Chr 4)
|
|
GS191129: GO:0016787 hydrolase activity
|
|
GS204150: GO:0009611 response to wounding
|
|
GS136540: psoriasis susceptibility 6 (Psrs6, Published QTL Chr 4)
|
|
GS193285: GO:0004623 phospholipase A2 activity
|
|
GS195897: GO:0044255 cellular lipid metabolic process
|
|
GS135607: circulating hormone level QTL 16 (Chlq16, Published QTL Chr 4)
|
|
GS135856: femoral bone morphometry 5 (Fembm5, Published QTL Chr 4)
|
|
GS180166: GO:0008152 metabolic process
|
|
GS135394: body growth early QTL 3 (Bgeq3, Published QTL Chr 4)
|
|
GS206742: GO:0043167 ion binding
|
|
GS136772: SGC/Knj cross B6 QTL 1 (Sxbq1, Published QTL Chr 4)
|
|
GS206547: GO:0036149 phosphatidylinositol acyl-chain remodeling
|
|
GS136580: red blood cell QTL 2 (Rbcq2, Published QTL Chr 4)
|
|
GS204384: GO:0006576 cellular biogenic amine metabolic process
|
|
GS206870: GO:0006654 phosphatidic acid biosynthetic process
|
|
GS136916: vertebral morphology and mechanical traits 4 (Vmmt4, Published QTL Chr 4)
|
|
GS209010: GO:1901575 organic substance catabolic process
|
|
GS210230: GO:0004623 phospholipase A2 activity
|
|
GS135350: Alzheimer's disease modifier 2 (Azdm2, Published QTL Chr 4)
|
|
GS206909: GO:0006952 defense response
|
|
GS135894: gastritis type A susceptibility locus 2 (Gasa2, Published QTL Chr 4)
|
|
GS198640: GO:0046470 phosphatidylcholine metabolic process
|
|
GS181473: GO:0005488 binding
|
|
GS136100: lupus NZB x NZW 2 (Lbw2, Published QTL Chr 4)
|
|
GS193812: GO:0006629 lipid metabolic process
|
|
GS83985: cocaine related behavior 16 (Cocrb16, Published QTL, Chr 4)
|
|
GS26269: Striatum Gene expression correlates of Mechanical Sensitivity-Von Frey Threshold in Females BXD
|
|
GS192512: GO:0003824 catalytic activity
|
|
GS198641: GO:0046473 phosphatidic acid metabolic process
|
|
GS136191: light induced retinal degeneration 2 (Lrdg2, Published QTL Chr 4)
|
|
GS195214: GO:0009987 cellular process
|
|
GS129104: bone mineral density 7 (Bmd7 Published QTL Chr 4)
|
|
GS198636: GO:0046474 glycerophospholipid biosynthetic process
|